FI952071A - Med trombin aktiverbara plasminogenderivat - Google Patents

Med trombin aktiverbara plasminogenderivat Download PDF

Info

Publication number
FI952071A
FI952071A FI952071A FI952071A FI952071A FI 952071 A FI952071 A FI 952071A FI 952071 A FI952071 A FI 952071A FI 952071 A FI952071 A FI 952071A FI 952071 A FI952071 A FI 952071A
Authority
FI
Finland
Prior art keywords
thrombin
amino acid
acid residue
thrombin activatable
activatable plasminogen
Prior art date
Application number
FI952071A
Other languages
English (en)
Finnish (fi)
Other versions
FI952071A0 (sv
FI114102B (sv
Inventor
Richard James Gilbert
Michael George Hulnter
Keith Martyn Dawson
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of FI952071A publication Critical patent/FI952071A/sv
Publication of FI952071A0 publication Critical patent/FI952071A0/sv
Application granted granted Critical
Publication of FI114102B publication Critical patent/FI114102B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
FI952071A 1992-10-29 1995-04-28 Förfarande för att framställa en plasminogenanalog som spjälks under effekten av trombin FI114102B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929222758A GB9222758D0 (en) 1992-10-29 1992-10-29 Proteins and nucleic acids
GB9222758 1992-10-29
GB9302219 1993-10-28
PCT/GB1993/002219 WO1994010318A1 (en) 1992-10-29 1993-10-28 Thrombin activatable plasminogen derivatives

Publications (3)

Publication Number Publication Date
FI952071A true FI952071A (sv) 1995-04-28
FI952071A0 FI952071A0 (sv) 1995-04-28
FI114102B FI114102B (sv) 2004-08-13

Family

ID=10724266

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952071A FI114102B (sv) 1992-10-29 1995-04-28 Förfarande för att framställa en plasminogenanalog som spjälks under effekten av trombin

Country Status (15)

Country Link
EP (1) EP0666920B1 (sv)
JP (1) JP3329340B2 (sv)
AT (1) ATE171213T1 (sv)
AU (1) AU674180B2 (sv)
CA (1) CA2145749C (sv)
DE (1) DE69321134T2 (sv)
DK (1) DK0666920T3 (sv)
ES (1) ES2123669T3 (sv)
FI (1) FI114102B (sv)
GB (1) GB9222758D0 (sv)
HK (1) HK1008047A1 (sv)
NO (1) NO317661B1 (sv)
NZ (1) NZ257175A (sv)
WO (1) WO1994010318A1 (sv)
ZA (1) ZA938120B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
BR9711015A (pt) * 1996-08-02 1999-08-17 Boehringer Mannheim Gmbh Ativador de plasminog-nio capaz de ser ativado por trombina
AU2002218890A1 (en) 2000-12-21 2002-07-01 Thromb-X N.V. A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
WO2003066842A2 (de) * 2002-02-06 2003-08-14 Trommsdorff Gmbh & Co. Kg Arzneimittel Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen
FR2841904B1 (fr) * 2002-07-03 2004-08-20 Inst Nat Sante Rech Med Analogues de facteurs x clivables par la thrombine
PL213309B1 (pl) 2006-02-09 2013-02-28 Polska Akademia Nauk Inst Biochemii I Biofizyki Sposób hydrolizy wiazania peptydowego

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids

Also Published As

Publication number Publication date
GB9222758D0 (en) 1992-12-09
ES2123669T3 (es) 1999-01-16
NZ257175A (en) 1996-07-26
NO317661B1 (no) 2004-11-29
AU674180B2 (en) 1996-12-12
EP0666920A1 (en) 1995-08-16
DK0666920T3 (da) 1999-06-14
DE69321134D1 (de) 1998-10-22
EP0666920B1 (en) 1998-09-16
CA2145749C (en) 2005-06-21
NO951648D0 (no) 1995-04-28
DE69321134T2 (de) 1999-02-25
JP3329340B2 (ja) 2002-09-30
CA2145749A1 (en) 1994-05-11
JPH08504575A (ja) 1996-05-21
ZA938120B (en) 1994-08-01
FI952071A0 (sv) 1995-04-28
HK1008047A1 (en) 1999-04-30
WO1994010318A1 (en) 1994-05-11
ATE171213T1 (de) 1998-10-15
FI114102B (sv) 2004-08-13
AU5343294A (en) 1994-05-24
NO951648L (no) 1995-04-28

Similar Documents

Publication Publication Date Title
AU605124B2 (en) Novel peptide plasminogen activators
DK0788509T3 (da) Terapeutiske peptidderivater
MY119155A (en) New peptide derivatives
DK0559019T3 (da) 14-beta-hydroxy-10-deacetyl-baccatin III og derivater deraf som antitumormidler
FI892507A0 (fi) Terapeutiska peptider.
DE69327796D1 (de) Antiproliferative substituierte 5-thiapyrimidinon- und 5-selenopyrimidinonverbindungen
FI942423A (sv) Sackarinderivat som inhibitorer för proteolytiska enzymer
ES2088860T3 (es) Activador plasminogenico de tipo tisular humano modificado y su preparacion.
FI952071A (sv) Med trombin aktiverbara plasminogenderivat
UA27132C2 (uk) Двофуhкціоhальhі варіаhти урокіhази зі зміцнеhою фібриhолітичhою властивістю і тромбіh-іhгібуючою дією
GB2286190A (en) Thrombin activatable plasminogen derivatives
NZ211632A (en) Substituted aminothiol dipeptide derivatives and intermediates
DK0589741T3 (da) Anvendelse af en direkte thrombininhibitor til fremstilling af et lægemiddel med thrombolytisk aktivitet
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
EP0326013A3 (en) Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
BR9810031A (pt) Derivados de ácido pirrolidina carboxìlico como antagonistas á endotelina